Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response

The humoral and cellular response to SARS-CoV-2 mRNA full vaccination and booster dose as well as the impact of the spike variants, including Omicron, are still unclear in patients with multiple myeloma (MM) and those with pre-malignant monoclonal gammopathies. In this study, involving 40 patients,...

Descripción completa

Detalles Bibliográficos
Autores principales: Storti, Paola, Marchica, Valentina, Vescovini, Rosanna, Franceschi, Valentina, Russo, Luca, Notarfranchi, Laura, Raimondi, Vincenzo, Toscani, Denise, Burroughs Garcia, Jessica, Costa, Federica, Dalla Palma, Benedetta, Iannozzi, Nicolas Thomas, Sammarelli, Gabriella, Donofrio, Gaetano, Giuliani, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467550/
https://www.ncbi.nlm.nih.gov/pubmed/36105747
http://dx.doi.org/10.1080/2162402X.2022.2120275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467550/
https://www.ncbi.nlm.nih.gov/pubmed/36105747
http://dx.doi.org/10.1080/2162402X.2022.2120275

Ejemplares similares